Wasserstein A - Search Results

1

Physical examination versus normalized pressure ratio for predicting outcomes of hemodialysis access interventions.

Trerotola SO, Ponce P, Stavropoulos SW, Clark TW, Tuite CM, Mondschein JI, Shlansky-Goldberg R, Freiman DB, Patel AA, Soulen MC, Cohen R, Wasserstein A, Chittams JL. Trerotola SO, et al. Among authors: wasserstein a. J Vasc Interv Radiol. 2003 Nov;14(11):1387-94. doi: 10.1097/01.rvi.0000096760.74047.34. J Vasc Interv Radiol. 2003. PMID: 14605103

2

Pulmonary hypertension among end-stage renal failure patients following hemodialysis access thrombectomy.

Harp RJ, Stavropoulos SW, Wasserstein AG, Clark TW. Harp RJ, et al. Cardiovasc Intervent Radiol. 2005 Jan-Feb;28(1):17-22. doi: 10.1007/s00270-004-0223-1. Cardiovasc Intervent Radiol. 2005. PMID: 15772721

3

Effectiveness of a two-part educational intervention to improve hypertension control: a cluster-randomized trial.

Hennessy S, Leonard CE, Yang W, Kimmel SE, Townsend RR, Wasserstein AG, Ten Have TR, Bilker WB. Hennessy S, et al. Pharmacotherapy. 2006 Sep;26(9):1342-7. doi: 10.1592/phco.26.9.1342. Pharmacotherapy. 2006. PMID: 16945057 Clinical Trial.

4

Willingness of dialysis patients to participate in a randomized controlled trial of daily dialysis.

Israni AK, Halpern SD, McFadden C, Israni RK, Wasserstein A, Kobrin S, Berns JS. Israni AK, et al. Among authors: wasserstein a. Kidney Int. 2004 Mar;65(3):990-8. doi: 10.1111/j.1523-1755.2004.00460.x. Kidney Int. 2004. PMID: 14871419 Free article.

5

Reprocessing of hemodialyzers: a critical appraisal.

Shusterman NH, Feldman HI, Wasserstein A, Strom BL. Shusterman NH, et al. Among authors: wasserstein a. Am J Kidney Dis. 1989 Aug;14(2):81-91. doi: 10.1016/s0272-6386(89)80181-7. Am J Kidney Dis. 1989. PMID: 2667347 Free article. Review.

6

Hemodialysis vascular access morbidity.

Feldman HI, Kobrin S, Wasserstein A. Feldman HI, et al. Among authors: wasserstein a. J Am Soc Nephrol. 1996 Apr;7(4):523-35. doi: 10.1681/ASN.V74523. J Am Soc Nephrol. 1996. PMID: 8724885 Review.

7

Recombinant human erythropoietin usage in a large academic medical center.

Bilenker JH, Demers R, Porter DL, Wasserstein AG, Peters E, Manaker S. Bilenker JH, et al. Am J Manag Care. 2002 Aug;8(8):742-7. Am J Manag Care. 2002. PMID: 12212761 Free article.

8

Changing patterns of medical practice: protein restriction for chronic renal failure.

Wasserstein AG. Wasserstein AG. Ann Intern Med. 1993 Jul 1;119(1):79-85. doi: 10.7326/0003-4819-119-1-199307010-00013. Ann Intern Med. 1993. PMID: 8498767

9

Preliminary observations of sildenafil treatment for erectile dysfunction in dialysis patients.

Rosas SE, Wasserstein A, Kobrin S, Feldman HI. Rosas SE, et al. Among authors: wasserstein a. Am J Kidney Dis. 2001 Jan;37(1):134-137. doi: 10.1053/ajkd.2001.20608. Am J Kidney Dis. 2001. PMID: 11136178 Clinical Trial.

10

Membranous glomerulonephritis.

Wasserstein AG. Wasserstein AG. J Am Soc Nephrol. 1997 Apr;8(4):664-74. doi: 10.1681/ASN.V84664. J Am Soc Nephrol. 1997. PMID: 10495797 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

80 results

Search Page

Filters